Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 28 for Genentech Inc.�
Company Exchange Symbol Last price Quote change Market cap
Roche Holding Ltd. VTX ROG 265.00 +1.80 (0.68%) 228.26B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Roche Holding Ltd. (ADR) OTCMKTS RHHBY 34.29 +0.04 (0.12%) 235.77B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Seattle Genetics, Inc. NASDAQ SGEN 36.16 -0.06 (-0.17%) 4.50B
Seattle Genetics, Inc. is a biotechnology Company focused on developing and commercializing antibody-based therapies for the treatment of cancer.
PDL BioPharma Inc NASDAQ PDLI 7.18 +0.14 (2.06%) 1.17B
PDL BioPharma, Inc. (PDL) is a biotech company. The Company is engaged in managing a portfolio of patents and royalty assets, consisting primarily of its ...
Biogen Inc NASDAQ BIIB 431.87 +2.00 (0.47%) 101.32B
Biogen Inc., formerly Biogen Idec Inc., is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the ...
ImmunoGen, Inc. NASDAQ IMGN 8.52 +0.27 (3.27%) 733.63M
ImmunoGen, Inc. is a biotechnology company. The Company develops targeted anticancer therapeutics. The Company has three wholly-owned product candidates in ...
Array Biopharma Inc NASDAQ ARRY 7.49 +0.09 (1.22%) 1.05B
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
Albany Molecular Research, Inc. NASDAQ AMRI 17.75 +0.19 (1.08%) 581.23M
Albany Molecular Research, Inc. (AMRI) is a contract research and manufacturing company. The Company provides customers with fully integrated drug discovery ...
ROCHE HLDG AG DIV RT OTCMKTS RHHVF 272.99 0.00 (0.00%) 191.79B
Exelixis, Inc. NASDAQ EXEL 2.62 +0.08 (3.15%) 513.25M
Exelixis, Inc., is a biotechnology company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
ROCHE HLDGS AG BEARE OTCMKTS RHHBF 269.10 0.00 (0.00%) 43.06B
Roche Holding AG FRA RHO5
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
ROCHE HLDG AG INH. SF 1 ETR RHO 252.55 +4.35 (1.75%)
ROCHE HLDG AG INH. SF 1 FRA RHO 252.00 +2.96 (1.19%)
Roche Holding Ltd. (Bearer Share) SWX RO 263.00 +1.75 (0.67%)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Aptose Biosciences Inc NASDAQ APTO 5.53 -0.02 (-0.29%) 65.62M
Aptose Biosciences Inc is a clinical-stage biotechnology company. The Company is engaged in discovering and developing personalized therapies addressing ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 6.44 -0.08 (-1.24%)
Xenon Pharmaceuticals Inc NASDAQ XENE 17.27 +0.52 (3.11%) 245.17M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...